In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Sue Darcey

Senior Reporter

Washington, D.C.
Sue Darcey is a senior reporter covering the medical device and diagnostics industry. Her current fields of expertise and interest include monitoring medical device post market performance and safety, development of new genomic and laboratory developed tests, the influence of industry lobbying and campaign contributions over Senators’ and Representatives’ voting practices and lawmaking on devices, and FDA approvals of diagnostics for emerging diseases, including tests for Ebola and Zika viruses. A Washington, D.C.-based trade journalist with over 30 years’ experience covering Capitol Hill and regulatory agencies including FDA, CMS and the Environmental Protection Agency, Sue is constantly on the look-out for any problems or safety issues connected to device use, ways that firms resolve those issues, and any new regulations that arise from the challenges. 

Latest From Sue Darcey

Health Care Coalition Asks Congress For Permanent Telemedicine Incentives

A coalition of health groups, medtech and telemedicine associations, and patient groups want the US Congress to permanently enact telehealth use reforms allowed only during the COVID-19 pandemic.

Policy Telehealth

Senators: Lack Of Full Coverage For Coronavirus Testing In US A Barrier To COVID-19 Surveillance

Asymptomatic people in the US are receiving bills for COVID-19 tests they get for work or travel – and some are refusing tests to avoid the costs, senators tell health care agency officials.

Policy Legislation

Tens Of Millions Of Medtech Users Stand To Lose Device Coverage If Feds Succeed In Texas v. US Brief

Approximately 23 million US citizens now covered by health care exchanges will lose insurance for their devices if Trump administration lawyers are successful in their most recent efforts to make the ACA null and void.

Policy Legal Issues

In Vitro Diagnostic Industry’s Political Playbook Rewritten As Firms Lobby On COVID-19 Legislation

Test kit and lab firms spent tens of thousands of dollars in the first quarter of 2020 lobbying legislators to win provisions in coronavirus protection laws to ensure COVID-19 diagnostics would be a top US legislative priority.

Policy Lobbying

Senate Bills Would Require More COVID-19 PPE, US Manufacturing Capacity, Use Of Analytical Imaging

Legislators at a 23 June Senate health panel hearing exploring prevention of future pandemics similar to COVID-19 discussed legislation they have recently introduced to resolve the current viral crisis.

Legislation Policy

Senators Push Back On Global Digital Taxes, While US Pulls Out Of OECD Technology Tax Talks

Two US senators said last week that Organization for Economic Cooperation and Development (OECD) member countries should drop plans to impose digital taxes on US businesses – a scheme that would impact firms that make digital health devices, including Apple, Siemens, Johnson & Johnson and IBM.

Policy Digital Health
See All